The Thing From the Deep Fryer! Fatty Liver, Epigenetics & the Positives of Weight Loss Medications

In this episode, Dr Richard Ralph and Dan Lowry explore the latest breakthroughs in the world of weight loss and metabolic health.

What’s inside:

• The rise (and fall) of Saxenda and why Wegovy is taking over the market
• How GLP-1 medications are changing the fight against obesity
• The hidden costs and benefits of these medications, and what the TGA approval means for you
• Eye-opening research on fatty liver disease, the gut microbiome and epigenetics
• The real science behind body transformation, sustainable health and long-term weight management

Plus, insights from Associate Professor Kevin Lee on the future of metabolic health.

Whether you’re considering medication, working on lifestyle changes or just curious about the science, this episode is packed with practical advice and evidence-based perspectives.

Subscribe for more conversations that challenge the status quo of health and wellness.

#WeightLoss #GLP1 #Saxenda #Wegovy #Obesity #FattyLiverDisease #GutMicrobiome #Epigenetics #SANAMethodPodcast